Jan Erik Varhaug
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jan Erik Varhaug has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Darina Gromyko
Department of Surgery, Haukeland University Hospital, N-5021 Bergen, Norway
1 shared publication - Hans Geir Eiken
Division of Environment and Natural Resources, Norwegian Institute of Bioeconomy Research , Ås
1 shared publication - Johan Richard Lillehaug
Department of Molecular Biology, University of Bergen, Bergen, Norway
1 shared publication - Kristian K. Starheim
CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway
1 shared publication - Lars Andreas Akslen
Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine University of Bergen Bergen Norway
1 shared publication - Ove Bruland
Center of Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
1 shared publication
Latest Publications
- Open Access
- 6 May 2011
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 131 (8) , 842
Farlig blått?
- 6 May 2011
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 131 (8) , 842
Open AccessFarlig blått?
- Open Access
- 9 December 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 425
Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas
Members of the PDGF family have been suggested as potential biomarkers for papillary thyroid carcinomas (PTC). However, it is known that both expression and stimulatory effect of PDGF ligands can be affected by inflammatory cytokines. We have performed a microarray study in a collection of PTCs, of which about half the biopsies contained tumour-infiltrating lymphocytes or thyroiditis. To investigate the expression level of PDGF ligands and receptors in PTC we measured the relative mRNA expression of all members of the PDGF family by qRT-PCR in 10 classical PTC, eight clinically aggressive PTC, and five non-neoplastic thyroid specimens, and integrated qRT-PCR data with microarray data to enable us to link PDGF-associated gene expression profiles into networks based on recognized interactions. Finally, we investigated potential influence on PDGF mRNA levels by the presence of tumour-infiltrating lymphocytes.
- 9 December 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 425
Open AccessInverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas
Members of the PDGF family have been suggested as potential biomarkers for papillary thyroid carcinomas (PTC). However, it is known that both expression and stimulatory effect of PDGF ligands can be affected by inflammatory cytokines. We have performed a microarray study in a collection of PTCs, of which about half the biopsies contained tumour-infiltrating lymphocytes or thyroiditis. To investigate the expression level of PDGF ligands and receptors in PTC we measured the relative mRNA expression of all members of the PDGF family by qRT-PCR in 10 classical PTC, eight clinically aggressive PTC, and five non-neoplastic thyroid specimens, and integrated qRT-PCR data with microarray data to enable us to link PDGF-associated gene expression profiles into networks based on recognized interactions. Finally, we investigated potential influence on PDGF mRNA levels by the presence of tumour-infiltrating lymphocytes.
- Open Access
- 4 August 2009
- Published by Springer Nature in BMC Proceedings
- Vol. 3 (S6) , S3
Composition and biological significance of the human Nα-terminal acetyltransferases
Protein Nα-terminal acetylation is one of the most common protein modifications in eukaryotic cells, occurring on approximately 80% of soluble human proteins. An increasing number of studies links Nα-terminal acetylation to cell differentiation, cell cycle, cell survival, and cancer. Thus, Nα-terminal acetylation is an essential modification for normal cell function in humans. Still, little is known about the functional role of Nα-terminal acetylation. Recently, the three major human N-acetyltransferase complexes, hNatA, hNatB and hNatC, were identified and characterized. We here summarize the identified N-terminal acetyltransferase complexes in humans, and we review the biological studies on Nα-terminal acetylation in humans and other higher eukaryotes.
- 4 August 2009
- Published by Springer Nature in BMC Proceedings
- Vol. 3 (S6) , S3
Open AccessComposition and biological significance of the human Nα-terminal acetyltransferases
Protein Nα-terminal acetylation is one of the most common protein modifications in eukaryotic cells, occurring on approximately 80% of soluble human proteins. An increasing number of studies links Nα-terminal acetylation to cell differentiation, cell cycle, cell survival, and cancer. Thus, Nα-terminal acetylation is an essential modification for normal cell function in humans. Still, little is known about the functional role of Nα-terminal acetylation. Recently, the three major human N-acetyltransferase complexes, hNatA, hNatB and hNatC, were identified and characterized. We here summarize the identified N-terminal acetyltransferase complexes in humans, and we review the biological studies on Nα-terminal acetylation in humans and other higher eukaryotes.